APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Albendazole Tablets Industry Research Report 2026

27 December 2025148 pages

Choose your research edition.

Industry ResearchAlbendazole Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Tablets Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Albendazole Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Tablets Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Tablets Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Albendazole Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Albendazole Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Albendazole Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Albendazole Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Albendazole Tablets include Chongqing Kerui Pharmaceutical (Group) Co., Ltd., Zhejiang Anbet Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Ningxia Qiyuan National Pharmaceutical Co., Ltd., Longhui Pharmaceutical Co., Ltd., Huazhong Pharmaceutical Co., Ltd. and Hubei Ruihua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Albendazole Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Albendazole Tablets Market by Company

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Ningxia Qiyuan National Pharmaceutical Co., Ltd.

Longhui Pharmaceutical Co., Ltd.

Huazhong Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

Hubei Meibao Pharmaceutical Co., Ltd.

Hubei Kelun Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Anhui Shengying Pharmaceutical Co., Ltd.

Teva

Sequent Scientific

Salius Pharma

Lasa Supergenerics Limited

K.A. Malle Pharmaceuticals

GlaxoSmithKline

Fredun Pharmaceuticals Ltd

AdvaCare Pharma

Aden

Albendazole Tablets Segment by Type

0.1g

0.2g

Albendazole Tablets Segment by Application

For Veterinary Use

For Human Use

Albendazole Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Albendazole Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Albendazole Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Albendazole Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Albendazole Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Albendazole Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Albendazole Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Albendazole Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Albendazole Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Albendazole Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Albendazole Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Albendazole Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Albendazole Tablets, Product Type & Application Table 14. Global Albendazole Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Albendazole Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 19. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 20. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio Table 22. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments Table 23. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 24. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 25. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 27. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments Table 28. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 29. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 30. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 32. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments Table 33. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 34. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 35. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio Table 37. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments Table 38. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 39. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 40. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 42. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments Table 43. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information Table 44. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview Table 45. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 47. Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Developments Table 48. Longhui Pharmaceutical Co., Ltd. Company Information Table 49. Longhui Pharmaceutical Co., Ltd. Business Overview Table 50. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 52. Longhui Pharmaceutical Co., Ltd. Recent Developments Table 53. Huazhong Pharmaceutical Co., Ltd. Company Information Table 54. Huazhong Pharmaceutical Co., Ltd. Business Overview Table 55. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 57. Huazhong Pharmaceutical Co., Ltd. Recent Developments Table 58. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 59. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 60. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 62. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments Table 63. Hubei Meibao Pharmaceutical Co., Ltd. Company Information Table 64. Hubei Meibao Pharmaceutical Co., Ltd. Business Overview Table 65. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 67. Hubei Meibao Pharmaceutical Co., Ltd. Recent Developments Table 68. Hubei Kelun Pharmaceutical Co., Ltd. Company Information Table 69. Hubei Kelun Pharmaceutical Co., Ltd. Business Overview Table 70. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 72. Hubei Kelun Pharmaceutical Co., Ltd. Recent Developments Table 73. Hubei Guangji Pharmaceutical Co., Ltd. Company Information Table 74. Hubei Guangji Pharmaceutical Co., Ltd. Business Overview Table 75. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 77. Hubei Guangji Pharmaceutical Co., Ltd. Recent Developments Table 78. Henan Runhong Pharmaceutical Co., Ltd. Company Information Table 79. Henan Runhong Pharmaceutical Co., Ltd. Business Overview Table 80. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 82. Henan Runhong Pharmaceutical Co., Ltd. Recent Developments Table 83. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 84. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 85. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 87. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments Table 88. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 89. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 90. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 92. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments Table 93. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 94. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 95. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio Table 97. Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments Table 98. Teva Company Information Table 99. Teva Business Overview Table 100. Teva Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Teva Albendazole Tablets Product Portfolio Table 102. Teva Recent Developments Table 103. Sequent Scientific Company Information Table 104. Sequent Scientific Business Overview Table 105. Sequent Scientific Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sequent Scientific Albendazole Tablets Product Portfolio Table 107. Sequent Scientific Recent Developments Table 108. Salius Pharma Company Information Table 109. Salius Pharma Business Overview Table 110. Salius Pharma Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Salius Pharma Albendazole Tablets Product Portfolio Table 112. Salius Pharma Recent Developments Table 113. Lasa Supergenerics Limited Company Information Table 114. Lasa Supergenerics Limited Business Overview Table 115. Lasa Supergenerics Limited Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Lasa Supergenerics Limited Albendazole Tablets Product Portfolio Table 117. Lasa Supergenerics Limited Recent Developments Table 118. K.A. Malle Pharmaceuticals Company Information Table 119. K.A. Malle Pharmaceuticals Business Overview Table 120. K.A. Malle Pharmaceuticals Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio Table 122. K.A. Malle Pharmaceuticals Recent Developments Table 123. GlaxoSmithKline Company Information Table 124. GlaxoSmithKline Business Overview Table 125. GlaxoSmithKline Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. GlaxoSmithKline Albendazole Tablets Product Portfolio Table 127. GlaxoSmithKline Recent Developments Table 128. Fredun Pharmaceuticals Ltd Company Information Table 129. Fredun Pharmaceuticals Ltd Business Overview Table 130. Fredun Pharmaceuticals Ltd Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio Table 132. Fredun Pharmaceuticals Ltd Recent Developments Table 133. AdvaCare Pharma Company Information Table 134. AdvaCare Pharma Business Overview Table 135. AdvaCare Pharma Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AdvaCare Pharma Albendazole Tablets Product Portfolio Table 137. AdvaCare Pharma Recent Developments Table 138. Aden Company Information Table 139. Aden Business Overview Table 140. Aden Albendazole Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Aden Albendazole Tablets Product Portfolio Table 142. Aden Recent Developments Table 143. Global Albendazole Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 144. Global Albendazole Tablets Sales by Region (2021-2026) & (K Units) Table 145. Global Albendazole Tablets Sales Market Share by Region (2021-2026) Table 146. Global Albendazole Tablets Sales by Region (2027-2032) & (K Units) Table 147. Global Albendazole Tablets Sales Market Share by Region (2027-2032) Table 148. Global Albendazole Tablets Revenue by Region (2021-2026) & (US$ Million) Table 149. Global Albendazole Tablets Revenue Market Share by Region (2021-2026) Table 150. Global Albendazole Tablets Revenue by Region (2027-2032) & (US$ Million) Table 151. Global Albendazole Tablets Revenue Market Share by Region (2027-2032) Table 152. North America Albendazole Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. North America Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 154. North America Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 155. North America Albendazole Tablets Revenue by Country (2021-2026) & (US$ Million) Table 156. North America Albendazole Tablets Revenue by Country (2027-2032) & (US$ Million) Table 157. Europe Albendazole Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Europe Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 159. Europe Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 160. Europe Albendazole Tablets Revenue by Country (2021-2026) & (US$ Million) Table 161. Europe Albendazole Tablets Revenue by Country (2027-2032) & (US$ Million) Table 162. Asia Pacific Albendazole Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Asia Pacific Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 164. Asia Pacific Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 165. Asia Pacific Albendazole Tablets Revenue by Country (2021-2026) & (US$ Million) Table 166. Asia Pacific Albendazole Tablets Revenue by Country (2027-2032) & (US$ Million) Table 167. South America Albendazole Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. South America Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 169. South America Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 170. South America Albendazole Tablets Revenue by Country (2021-2026) & (US$ Million) Table 171. South America Albendazole Tablets Revenue by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Albendazole Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. Middle East and Africa Albendazole Tablets Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Albendazole Tablets Sales by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Albendazole Tablets Revenue by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Albendazole Tablets Revenue by Country (2027-2032) & (US$ Million) Table 177. Global Albendazole Tablets Sales by Type (2021-2026) & (K Units) Table 178. Global Albendazole Tablets Sales by Type (2027-2032) & (K Units) Table 179. Global Albendazole Tablets Sales Market Share by Type (2021-2026) Table 180. Global Albendazole Tablets Sales Market Share by Type (2027-2032) Table 181. Global Albendazole Tablets Revenue by Type (2021-2026) & (US$ Million) Table 182. Global Albendazole Tablets Revenue by Type (2027-2032) & (US$ Million) Table 183. Global Albendazole Tablets Revenue Market Share by Type (2021-2026) Table 184. Global Albendazole Tablets Revenue Market Share by Type (2027-2032) Table 185. Global Albendazole Tablets Price by Type (2021-2026) & (US$/Unit) Table 186. Global Albendazole Tablets Price by Type (2027-2032) & (US$/Unit) Table 187. Global Albendazole Tablets Sales by Application (2021-2026) & (K Units) Table 188. Global Albendazole Tablets Sales by Application (2027-2032) & (K Units) Table 189. Global Albendazole Tablets Sales Market Share by Application (2021-2026) Table 190. Global Albendazole Tablets Sales Market Share by Application (2027-2032) Table 191. Global Albendazole Tablets Revenue by Application (2021-2026) & (US$ Million) Table 192. Global Albendazole Tablets Revenue by Application (2027-2032) & (US$ Million) Table 193. Global Albendazole Tablets Revenue Market Share by Application (2021-2026) Table 194. Global Albendazole Tablets Revenue Market Share by Application (2027-2032) Table 195. Global Albendazole Tablets Price by Application (2021-2026) & (US$/Unit) Table 196. Global Albendazole Tablets Price by Application (2027-2032) & (US$/Unit) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Albendazole Tablets Distributors List Table 200. Albendazole Tablets Customers List Table 201. Albendazole Tablets Industry Trends Table 202. Albendazole Tablets Industry Drivers Table 203. Albendazole Tablets Industry Restraints Table 204. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Albendazole Tablets Product Image Figure 5. Global Albendazole Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Albendazole Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Albendazole Tablets Sales (2021-2032) & (K Units) Figure 8. Global Albendazole Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. 0.1g Product Image Figure 10. 0.2g Product Image Figure 11. For Veterinary Use Product Image Figure 12. For Human Use Product Image Figure 13. Global Albendazole Tablets Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Albendazole Tablets, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Albendazole Tablets Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Albendazole Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Albendazole Tablets Sales by Region in 2025 Figure 19. Global Albendazole Tablets Revenue by Region in 2025 Figure 20. North America Albendazole Tablets Market Size by Country in 2025 Figure 21. North America Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 22. North America Albendazole Tablets Revenue Market Share by Country (2021-2032) Figure 23. United States Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Albendazole Tablets Market Size by Country in 2025 Figure 27. Europe Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 28. Europe Albendazole Tablets Revenue Market Share by Country (2021-2032) Figure 29. Germany Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Albendazole Tablets Market Size by Country in 2025 Figure 40. Asia Pacific Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Albendazole Tablets Revenue Market Share by Country (2021-2032) Figure 42. China Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Albendazole Tablets Market Size by Country in 2025 Figure 51. South America Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 52. South America Albendazole Tablets Revenue Market Share by Country (2021-2032) Figure 53. Brazil Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Albendazole Tablets Market Size by Country in 2025 Figure 57. Middle East and Africa Albendazole Tablets Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Albendazole Tablets Revenue Market Share by Country (2021-2032) Figure 59. Egypt Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Albendazole Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Albendazole Tablets Sales Market Share by Type (2021-2032) Figure 65. Global Albendazole Tablets Revenue Market Share by Type (2021-2032) Figure 66. Global Albendazole Tablets Price (US$/Unit) by Type (2021-2032) Figure 67. Global Albendazole Tablets Sales Market Share by Application (2021-2032) Figure 68. Global Albendazole Tablets Revenue Market Share by Application (2021-2032) Figure 69. Global Albendazole Tablets Price (US$/Unit) by Application (2021-2032) Figure 70. Albendazole Tablets Value Chain Figure 71. Albendazole Tablets Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Albendazole Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  • Longhui Pharmaceutical Co., Ltd.
  • Huazhong Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • Hubei Meibao Pharmaceutical Co., Ltd.
  • Hubei Kelun Pharmaceutical Co., Ltd.
  • Hubei Guangji Pharmaceutical Co., Ltd.
  • Henan Runhong Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Teva
  • Sequent Scientific
  • Salius Pharma
  • Lasa Supergenerics Limited
  • K.A. Malle Pharmaceuticals
  • GlaxoSmithKline
  • Fredun Pharmaceuticals Ltd
  • AdvaCare Pharma
  • Aden

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Albendazole Tablets Market Size (2021-2032)
  4. 2.2.2 Global Albendazole Tablets Sales (2021-2032)
  5. 2.2.3 Global Albendazole Tablets Market Average Price (2021-2032)
  6. 2.3 Albendazole Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 0.1g
  9. 2.3.3 0.2g
  10. 2.4 Albendazole Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 For Veterinary Use
  13. 2.4.3 For Human Use
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Albendazole Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Albendazole Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Albendazole Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Albendazole Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Albendazole Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Albendazole Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Albendazole Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Albendazole Tablets, Established Date
  9. 3.9 Global Albendazole Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  2. 4.1.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  3. 4.1.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  4. 4.1.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Albendazole Tablets Product Portfolio
  6. 4.1.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
  7. 4.2 Zhejiang Anbet Pharmaceutical Co., Ltd.
  8. 4.2.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  12. 4.2.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Sichuan Tiande Pharmaceutical Co., Ltd.
  14. 4.3.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sichuan Tiande Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  18. 4.3.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  20. 4.4.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  21. 4.4.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  22. 4.4.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Albendazole Tablets Product Portfolio
  24. 4.4.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  25. 4.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 4.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  30. 4.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Ningxia Qiyuan National Pharmaceutical Co., Ltd.
  32. 4.6.1 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  36. 4.6.5 Ningxia Qiyuan National Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Longhui Pharmaceutical Co., Ltd.
  38. 4.7.1 Longhui Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Longhui Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Longhui Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  42. 4.7.5 Longhui Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Huazhong Pharmaceutical Co., Ltd.
  44. 4.8.1 Huazhong Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Huazhong Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Huazhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  48. 4.8.5 Huazhong Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Hubei Ruihua Pharmaceutical Co., Ltd.
  50. 4.9.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hubei Ruihua Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  54. 4.9.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Hubei Meibao Pharmaceutical Co., Ltd.
  56. 4.10.1 Hubei Meibao Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Hubei Meibao Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hubei Meibao Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  60. 4.10.5 Hubei Meibao Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Hubei Kelun Pharmaceutical Co., Ltd.
  62. 4.11.1 Hubei Kelun Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Hubei Kelun Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hubei Kelun Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  66. 4.11.5 Hubei Kelun Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Hubei Guangji Pharmaceutical Co., Ltd.
  68. 4.12.1 Hubei Guangji Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Hubei Guangji Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hubei Guangji Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  72. 4.12.5 Hubei Guangji Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Henan Runhong Pharmaceutical Co., Ltd.
  74. 4.13.1 Henan Runhong Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Henan Runhong Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Henan Runhong Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  78. 4.13.5 Henan Runhong Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  80. 4.14.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  84. 4.14.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  86. 4.15.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  90. 4.15.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Anhui Shengying Pharmaceutical Co., Ltd.
  92. 4.16.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Anhui Shengying Pharmaceutical Co., Ltd. Albendazole Tablets Product Portfolio
  96. 4.16.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Teva
  98. 4.17.1 Teva Company Information
  99. 4.17.2 Teva Business Overview
  100. 4.17.3 Teva Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Teva Albendazole Tablets Product Portfolio
  102. 4.17.5 Teva Recent Developments
  103. 4.18 Sequent Scientific
  104. 4.18.1 Sequent Scientific Company Information
  105. 4.18.2 Sequent Scientific Business Overview
  106. 4.18.3 Sequent Scientific Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Sequent Scientific Albendazole Tablets Product Portfolio
  108. 4.18.5 Sequent Scientific Recent Developments
  109. 4.19 Salius Pharma
  110. 4.19.1 Salius Pharma Company Information
  111. 4.19.2 Salius Pharma Business Overview
  112. 4.19.3 Salius Pharma Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Salius Pharma Albendazole Tablets Product Portfolio
  114. 4.19.5 Salius Pharma Recent Developments
  115. 4.20 Lasa Supergenerics Limited
  116. 4.20.1 Lasa Supergenerics Limited Company Information
  117. 4.20.2 Lasa Supergenerics Limited Business Overview
  118. 4.20.3 Lasa Supergenerics Limited Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Lasa Supergenerics Limited Albendazole Tablets Product Portfolio
  120. 4.20.5 Lasa Supergenerics Limited Recent Developments
  121. 4.21 K.A. Malle Pharmaceuticals
  122. 4.21.1 K.A. Malle Pharmaceuticals Company Information
  123. 4.21.2 K.A. Malle Pharmaceuticals Business Overview
  124. 4.21.3 K.A. Malle Pharmaceuticals Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 K.A. Malle Pharmaceuticals Albendazole Tablets Product Portfolio
  126. 4.21.5 K.A. Malle Pharmaceuticals Recent Developments
  127. 4.22 GlaxoSmithKline
  128. 4.22.1 GlaxoSmithKline Company Information
  129. 4.22.2 GlaxoSmithKline Business Overview
  130. 4.22.3 GlaxoSmithKline Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 GlaxoSmithKline Albendazole Tablets Product Portfolio
  132. 4.22.5 GlaxoSmithKline Recent Developments
  133. 4.23 Fredun Pharmaceuticals Ltd
  134. 4.23.1 Fredun Pharmaceuticals Ltd Company Information
  135. 4.23.2 Fredun Pharmaceuticals Ltd Business Overview
  136. 4.23.3 Fredun Pharmaceuticals Ltd Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Fredun Pharmaceuticals Ltd Albendazole Tablets Product Portfolio
  138. 4.23.5 Fredun Pharmaceuticals Ltd Recent Developments
  139. 4.24 AdvaCare Pharma
  140. 4.24.1 AdvaCare Pharma Company Information
  141. 4.24.2 AdvaCare Pharma Business Overview
  142. 4.24.3 AdvaCare Pharma Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 AdvaCare Pharma Albendazole Tablets Product Portfolio
  144. 4.24.5 AdvaCare Pharma Recent Developments
  145. 4.25 Aden
  146. 4.25.1 Aden Company Information
  147. 4.25.2 Aden Business Overview
  148. 4.25.3 Aden Albendazole Tablets Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Aden Albendazole Tablets Product Portfolio
  150. 4.25.5 Aden Recent Developments
5 Global Albendazole Tablets Market Scenario by Region
  1. 5.1 Global Albendazole Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Albendazole Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Albendazole Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Albendazole Tablets Sales by Region: 2027-2032
  5. 5.3 Global Albendazole Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Albendazole Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Albendazole Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Albendazole Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Albendazole Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Albendazole Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Albendazole Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Albendazole Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Albendazole Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Albendazole Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Albendazole Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Albendazole Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Albendazole Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Albendazole Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Albendazole Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Albendazole Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Albendazole Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Albendazole Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Albendazole Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Albendazole Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Albendazole Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Albendazole Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Albendazole Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Albendazole Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Albendazole Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Albendazole Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Albendazole Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Albendazole Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Albendazole Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Albendazole Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Albendazole Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Albendazole Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Albendazole Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Albendazole Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Albendazole Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Albendazole Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Albendazole Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Albendazole Tablets Value Chain Analysis
  2. 8.1.1 Albendazole Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Albendazole Tablets Production Mode & Process
  5. 8.2 Albendazole Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Albendazole Tablets Distributors
  8. 8.2.3 Albendazole Tablets Customers
9 Global Albendazole Tablets Analyzing Market Dynamics
  1. 9.1 Albendazole Tablets Industry Trends
  2. 9.2 Albendazole Tablets Industry Drivers
  3. 9.3 Albendazole Tablets Industry Opportunities and Challenges
  4. 9.4 Albendazole Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst